L
L. Lee Hamm
Researcher at Tulane University
Publications - 165
Citations - 17284
L. Lee Hamm is an academic researcher from Tulane University. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 48, co-authored 161 publications receiving 15469 citations. Previous affiliations of L. Lee Hamm include Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
Mark J. Sarnak,Andrew S. Levey,Anton C. Schoolwerth,Josef Coresh,Bruce F. Culleton,L. Lee Hamm,Peter A. McCullough,Bertram L. Kasiske,Ellie Kelepouris,Michael J. Klag,Patrick S. Parfrey,Marc A. Pfeffer,Leopoldo Raij,David J. Spinosa,Peter W.F. Wilson +14 more
TL;DR: There was a high prevalence of CVD in CKD and that mortality due to CVD was 10 to 30 times higher in dialysis patients than in the general population, and the task force recommended that patients with CKD be considered in the “highest risk group” for subsequent CVD events.
Journal ArticleDOI
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Mark J. Sarnak,Andrew S. Levey,Anton C. Schoolwerth,Josef Coresh,Bruce F. Culleton,L. Lee Hamm,Peter A. McCullough,Bertram L. Kasiske,Ellie Kelepouris,Michael J. Klag,Patrick S. Parfrey,Marc A. Pfeffer,Leopoldo Raij,David J. Spinosa,Peter W.F. Wilson +14 more
TL;DR: There was a high prevalence of CVD in CKD and that mortality due to CVD was 10 to 30 times higher in dialysis patients than in the general population, and the task force recommended that patients with CKD be considered in the “highest risk group” for subsequent CVD events.
Journal ArticleDOI
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
Tamara Isakova,Patricia Wahl,Gabriela Vargas,Orlando M. Gutiérrez,Julia J. Scialla,Huiliang Xie,Dina Appleby,Lisa Nessel,Keith Bellovich,Jing Chen,L. Lee Hamm,Crystal A. Gadegbeku,Edward Horwitz,Raymond R. Townsend,Cheryl A.M. Anderson,James P. Lash,Chi-yuan Hsu,Mary B. Leonard,Myles Wolf +18 more
TL;DR: Increased FGF23 is a common manifestation of CKD that develops earlier than increased phosphate or PTH, and may be a sensitive early biomarker of disordered phosphorus metabolism in patients with CKD and normal serum phosphate levels.
Journal ArticleDOI
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
TL;DR: This study indicates that, in a representative sample of the United States general population, renal insufficiency is independently associated with increased cardiovascular disease-related and all-cause mortality rates.
Journal ArticleDOI
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Harold I. Feldman,Lawrence J. Appel,Glenn M. Chertow,Denise Cifelli,Borut Cizman,John T. Daugirdas,Jeffrey C. Fink,Eunice D. Franklin-Becker,Alan S. Go,L. Lee Hamm,Jiang He,Tom Hostetter,Chi-yuan Hsu,Kenneth Jamerson,Marshall M. Joffe,John W. Kusek,J. Richard Landis,James P. Lash,Edgar R. Miller,Emile R. Mohler,Paul Muntner,Akinlolu O. Ojo,Mahboob Rahman,Raymond R. Townsend,Jackson T. Wright +24 more
TL;DR: The Chronic Renal Insufficiency Cohort Study was established to examine risk factors for progression of CRI and CVD among CRI patients and develop models to identify high-risk subgroups, informing future treatment trials, and increasing application of preventive therapies.